(Q34582919)

English

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

phase III clinical trial

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

peripheral neuropathy

1 reference

based on heuristic

inferred from title

Chemotherapy-induced peripheral neuropathy

1 reference

based on heuristic

inferred from title

author name string

Ravi D Rao

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

John C Michalak

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jeff A Sloan

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Charles L Loprinzi

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gamini S Soori

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniel A Nikcevich

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

David O Warner

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Paul Novotny

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Leila A Kutteh

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gilbert Y Wong

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

North Central Cancer Treatment Group

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2110-2118

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Quality of life in hospice patients. A pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

21 January 2018

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly cisplatin +- glutathione in relapsed ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

The short-form McGill Pain Questionnaire

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23008

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34582919&oldid=1547993030"